tizanidine 2 mg
1 INDICATIONS AND USAGE Tizanidine tablets are a central alpha-2-adrenergic agonist indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine tablets should be reserved for those daily activities and times when relief of spasticity is most important. ( 1 ) Tizanidine tablets are indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine tablets should be reserved for those daily activities and times when relief of spasticity is most important [ see Dosage and Administration (2.1) ] .
viona pharmaceuticals inc
ROUND WHITE I I 04
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
TIZANIDINE Tablets USP, 2 mg are white to off-white, round, uncoated tablet debossed with '1' & '1' on either side of bisecting score on one side and debossed with '04' on the other side and are supplied as follows: NDC 72578-096-06 in bottles of 30 tablets with child-resistant closure. NDC 72578-096-21 in bottles of 150 tablets with child-resistant closure. NDC 72578-096-10 in bottles of 1000 tablets NDC 72578-096-77 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets
TIZANIDINE Tablets USP, 4 mg are white to off-white, round, uncoated tablet with quadrisecting score on one side and debossed with '1105' on the other side and are supplied as follows: NDC 72578-097-06 in bottles of 30 tablets with child-resistant closure. NDC 72578-097-21 in bottles of 150 tablets with child-resistant closure. NDC 72578-097-76 in bottles of 300 tablets with child-resistant closure. NDC 72578-097-10 in bottles of 1000 tablets NDC 72578-097-77 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight container as defined in the USP with a child-resistant closure.
More pills like ROUND I I 04